NDC codes

FDA NDC Directory
Product NDC (as listed)70954-522Labeler and product segments. Claims need a package NDC.
Product NDC at billing width70954-0522Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
70954-522-107095405221080 mL in 1 BOTTLE (70954-522-10)Marketed from Jan 30, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Inzirqo
Generic name (nonproprietary)
hydrochlorothiazide
Active ingredients
Hydrochlorothiazide — 10 mg/mL
Dosage form
Powder, For suspension
Route
Oral
Labeler
ANI Pharmaceuticals, Inc.NDC labeler code 70954
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 219141
Marketing start
Listing expires
Other FDA classes
Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers
Product ID 70954-522_d6ace9b2-f8fa-42b9-8338-9e2b5519ef6bSPL ID d6ace9b2-f8fa-42b9-8338-9e2b5519ef6bSPL set ID 41aaea48-6c1b-42c8-a96f-5923d49dc934RxCUI 2704012, 2704018UNII 0J48LPH2THUPC 0370954522102
Pharmacologic class
Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470954052210 followed by a unit qualifier and the quantity

Package 70954-0522-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INZIRQO™ (hydrochlorothiazide) is a thiazide diuretic indicated for: The treatment of hypertension in adult and pediatric patients alone or in combination with other antihypertensive agents, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarction (1.1). The treatment of edema associated with congestive heart failure, hepatic cirrhosis and renal disease including the nephrotic syndrome in adult and pediatric patients. (1.2). 1.1 Hypertension INZIRQO is indicated for the treatment of hypertension in adult and pediatric patients, to lower blood pressure. Lowering blood pressure reduces the risk of…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70954-522

What is NDC 70954-522?
70954-522 is the product NDC for Inzirqo (hydrochlorothiazide), Hydrochlorothiazide 10 mg/mL powder, for suspension, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Inzirqo (Hydrochlorothiazide).
What is the active ingredient?
Hydrochlorothiazide.
Who is the labeler?
ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Inzirqo?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in